Venetoclax plus hypomethylating agent for the salvage treatment of relapsing myeloid malignancies after hematopoietic stem cell transplantation: A multicenter retrospective study on behalf of the Zhejiang Cooperative Group for Blood and Marrow Transplantation

Fei Gao; Yang Gao; Yi Luo; Jian Yu; Huarui Fu; Xiaoyu Lai; Lizhen Liu; Baodong Ye; Jianping Lan; Xiaolu Song; Ying Lu; Lieguang Chen; Yi Chen; Kang Yu; He Huang; Jimin Shi; Yanmin Zhao

doi:10.1002/ajh.26405

Venetoclax plus hypomethylating agent for the salvage treatment of relapsing myeloid malignancies after hematopoietic stem cell transplantation: A multicenter retrospective study on behalf of the Zhejiang Cooperative Group for Blood and Marrow Transplantation

Am J Hematol. 2022 Feb 1;97(2):E44-E47. doi: 10.1002/ajh.26405. Epub 2021 Nov 24.

Authors

Fei Gao^{1

2

3

4}, Yang Gao^{1

2

3

4}, Yi Luo^{1

2

3

4}, Jian Yu^{1

2

3

4}, Huarui Fu^{1

2

3

4}, Xiaoyu Lai^{1

2

3

4}, Lizhen Liu^{1

2

3

4}, Baodong Ye⁵, Jianping Lan⁶, Xiaolu Song⁶, Ying Lu⁷, Lieguang Chen⁷, Yi Chen⁸, Kang Yu⁸, He Huang^{1

2

3

4}, Jimin Shi^{1

2

3

4}, Yanmin Zhao^{1

2

3

4}

Affiliations

¹ Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
³ Institute of Hematology, Zhejiang University, Hangzhou, China.
⁴ Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
⁵ Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
⁶ Department of Hematology and Hematopoietic Stem Cell Transplant Center, Zhejiang Provincial People's Hospital, Hangzhou, China.
⁷ Department of Hematology, Yinzhou Hospital Affiliated to Medical School of Ningbo University, Ningbo, China.
⁸ Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

PMID: 34778993
DOI: 10.1002/ajh.26405

No abstract available

Publication types

Letter
Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents / therapeutic use*
Bridged Bicyclo Compounds, Heterocyclic / therapeutic use*
Female
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute / therapy*
Male
Myelodysplastic Syndromes / therapy*
Neoplasm Recurrence, Local / therapy*
Retrospective Studies
Salvage Therapy
Sulfonamides / therapeutic use*

Substances

Antineoplastic Agents
Bridged Bicyclo Compounds, Heterocyclic
Sulfonamides
venetoclax